nodes	percent_of_prediction	percent_of_DWPC	metapath
Spironolactone—NR3C1—glaucoma	0.66	1	CbGaD
Spironolactone—Discomfort—Methazolamide—glaucoma	0.00107	0.00446	CcSEcCtD
Spironolactone—Erectile dysfunction—Dorzolamide—glaucoma	0.00107	0.00445	CcSEcCtD
Spironolactone—Agranulocytosis—Acetazolamide—glaucoma	0.00105	0.00438	CcSEcCtD
Spironolactone—Erectile dysfunction—Brinzolamide—glaucoma	0.00105	0.00437	CcSEcCtD
Spironolactone—Confusional state—Methazolamide—glaucoma	0.00105	0.00436	CcSEcCtD
Spironolactone—Anaphylactic shock—Methazolamide—glaucoma	0.00104	0.00433	CcSEcCtD
Spironolactone—Discomfort—Latanoprost—glaucoma	0.00104	0.00432	CcSEcCtD
Spironolactone—Lethargy—Clonidine—glaucoma	0.00103	0.0043	CcSEcCtD
Spironolactone—Stevens-Johnson syndrome—Dorzolamide—glaucoma	0.00103	0.00427	CcSEcCtD
Spironolactone—Somnolence—Diclofenamide—glaucoma	0.001	0.00418	CcSEcCtD
Spironolactone—Gastrointestinal disorder—Diclofenamide—glaucoma	0.000976	0.00406	CcSEcCtD
Spironolactone—Agranulocytosis—Dorzolamide—glaucoma	0.000966	0.00402	CcSEcCtD
Spironolactone—Erythema multiforme—Acetazolamide—glaucoma	0.000959	0.00399	CcSEcCtD
Spironolactone—Feeling abnormal—Diclofenamide—glaucoma	0.000931	0.00387	CcSEcCtD
Spironolactone—Somnolence—Methazolamide—glaucoma	0.000925	0.00385	CcSEcCtD
Spironolactone—Ill-defined disorder—Apraclonidine—glaucoma	0.000915	0.00381	CcSEcCtD
Spironolactone—Hypersensitivity—Metipranolol—glaucoma	0.000914	0.0038	CcSEcCtD
Spironolactone—Cramp muscle—Clonidine—glaucoma	0.000913	0.00379	CcSEcCtD
Spironolactone—Hydrocortamate—NR3C1—glaucoma	0.000902	0.14	CrCbGaD
Spironolactone—Lethargy—Betaxolol—glaucoma	0.0009	0.00374	CcSEcCtD
Spironolactone—Gastrointestinal disorder—Methazolamide—glaucoma	0.000898	0.00374	CcSEcCtD
Spironolactone—Feeling abnormal—Levobunolol—glaucoma	0.000895	0.00372	CcSEcCtD
Spironolactone—Body temperature increased—Diclofenamide—glaucoma	0.000893	0.00371	CcSEcCtD
Spironolactone—Malaise—Apraclonidine—glaucoma	0.00089	0.0037	CcSEcCtD
Spironolactone—Cortisone acetate—NR3C1—glaucoma	0.000888	0.138	CrCbGaD
Spironolactone—Erythema multiforme—Dorzolamide—glaucoma	0.000879	0.00365	CcSEcCtD
Spironolactone—Body temperature increased—Carbachol—glaucoma	0.000872	0.00363	CcSEcCtD
Spironolactone—Urticaria—Levobunolol—glaucoma	0.000863	0.00359	CcSEcCtD
Spironolactone—Feeling abnormal—Methazolamide—glaucoma	0.000857	0.00357	CcSEcCtD
Spironolactone—Megestrol acetate—NR3C1—glaucoma	0.000856	0.133	CrCbGaD
Spironolactone—Hypersensitivity—Carteolol—glaucoma	0.000847	0.00352	CcSEcCtD
Spironolactone—Discomfort—Apraclonidine—glaucoma	0.00083	0.00345	CcSEcCtD
Spironolactone—Ataxia—Betaxolol—glaucoma	0.00083	0.00345	CcSEcCtD
Spironolactone—Urticaria—Methazolamide—glaucoma	0.000827	0.00344	CcSEcCtD
Spironolactone—Body temperature increased—Methazolamide—glaucoma	0.000823	0.00342	CcSEcCtD
Spironolactone—Alopecia—Dorzolamide—glaucoma	0.000821	0.00341	CcSEcCtD
Spironolactone—Dizziness—Metipranolol—glaucoma	0.00082	0.00341	CcSEcCtD
Spironolactone—Ill-defined disorder—Acetazolamide—glaucoma	0.000819	0.0034	CcSEcCtD
Spironolactone—Alopecia—Brinzolamide—glaucoma	0.000807	0.00336	CcSEcCtD
Spironolactone—Erectile dysfunction—Clonidine—glaucoma	0.000807	0.00335	CcSEcCtD
Spironolactone—Hypersensitivity—Levobunolol—glaucoma	0.0008	0.00333	CcSEcCtD
Spironolactone—Pruritus—Diclofenamide—glaucoma	0.000799	0.00332	CcSEcCtD
Spironolactone—Malaise—Acetazolamide—glaucoma	0.000796	0.00331	CcSEcCtD
Spironolactone—Cramp muscle—Betaxolol—glaucoma	0.000795	0.0033	CcSEcCtD
Spironolactone—Toxic epidermal necrolysis—Betaxolol—glaucoma	0.000795	0.0033	CcSEcCtD
Spironolactone—Leukopenia—Acetazolamide—glaucoma	0.00079	0.00328	CcSEcCtD
Spironolactone—Rash—Metipranolol—glaucoma	0.000782	0.00325	CcSEcCtD
Spironolactone—Dermatitis—Metipranolol—glaucoma	0.000782	0.00325	CcSEcCtD
Spironolactone—Drowsiness—Clonidine—glaucoma	0.000781	0.00325	CcSEcCtD
Spironolactone—Headache—Metipranolol—glaucoma	0.000777	0.00323	CcSEcCtD
Spironolactone—Alopecia—Pilocarpine—glaucoma	0.000776	0.00323	CcSEcCtD
Spironolactone—Pruritus—Levobunolol—glaucoma	0.000768	0.0032	CcSEcCtD
Spironolactone—Muscle spasms—Brinzolamide—glaucoma	0.000765	0.00318	CcSEcCtD
Spironolactone—Dizziness—Carteolol—glaucoma	0.00076	0.00316	CcSEcCtD
Spironolactone—Diarrhoea—Carbachol—glaucoma	0.000755	0.00314	CcSEcCtD
Spironolactone—Ill-defined disorder—Travoprost—glaucoma	0.000747	0.00311	CcSEcCtD
Spironolactone—Dizziness—Diclofenamide—glaucoma	0.000747	0.00311	CcSEcCtD
Spironolactone—Diarrhoea—Levobunolol—glaucoma	0.000743	0.00309	CcSEcCtD
Spironolactone—Discomfort—Acetazolamide—glaucoma	0.000742	0.00309	CcSEcCtD
Spironolactone—Ill-defined disorder—Brinzolamide—glaucoma	0.000738	0.00307	CcSEcCtD
Spironolactone—Nausea—Metipranolol—glaucoma	0.000737	0.00306	CcSEcCtD
Spironolactone—Muscle spasms—Pilocarpine—glaucoma	0.000735	0.00306	CcSEcCtD
Spironolactone—Dizziness—Carbachol—glaucoma	0.000729	0.00303	CcSEcCtD
Spironolactone—Malaise—Travoprost—glaucoma	0.000726	0.00302	CcSEcCtD
Spironolactone—Confusional state—Acetazolamide—glaucoma	0.000726	0.00302	CcSEcCtD
Spironolactone—Anaphylactic shock—Acetazolamide—glaucoma	0.00072	0.00299	CcSEcCtD
Spironolactone—Headache—Carteolol—glaucoma	0.00072	0.00299	CcSEcCtD
Spironolactone—Vomiting—Diclofenamide—glaucoma	0.000718	0.00299	CcSEcCtD
Spironolactone—Dizziness—Levobunolol—glaucoma	0.000718	0.00299	CcSEcCtD
Spironolactone—Malaise—Brinzolamide—glaucoma	0.000717	0.00298	CcSEcCtD
Spironolactone—Somnolence—Apraclonidine—glaucoma	0.000716	0.00298	CcSEcCtD
Spironolactone—Pruritus—Latanoprost—glaucoma	0.000713	0.00296	CcSEcCtD
Spironolactone—Rash—Diclofenamide—glaucoma	0.000713	0.00296	CcSEcCtD
Spironolactone—Discomfort—Brimonidine—glaucoma	0.000712	0.00296	CcSEcCtD
Spironolactone—Diarrhoea—Methazolamide—glaucoma	0.000712	0.00296	CcSEcCtD
Spironolactone—Headache—Diclofenamide—glaucoma	0.000708	0.00294	CcSEcCtD
Spironolactone—Thrombocytopenia—Acetazolamide—glaucoma	0.000705	0.00293	CcSEcCtD
Spironolactone—Fludrocortisone—NR3C1—glaucoma	0.000704	0.109	CrCbGaD
Spironolactone—Erectile dysfunction—Betaxolol—glaucoma	0.000702	0.00292	CcSEcCtD
Spironolactone—Vomiting—Carbachol—glaucoma	0.000701	0.00292	CcSEcCtD
Spironolactone—Rash—Carbachol—glaucoma	0.000695	0.00289	CcSEcCtD
Spironolactone—Gastrointestinal disorder—Apraclonidine—glaucoma	0.000695	0.00289	CcSEcCtD
Spironolactone—Dermatitis—Carbachol—glaucoma	0.000695	0.00289	CcSEcCtD
Spironolactone—Somnolence—Bimatoprost—glaucoma	0.000694	0.00289	CcSEcCtD
Spironolactone—Headache—Carbachol—glaucoma	0.000691	0.00287	CcSEcCtD
Spironolactone—Leukopenia—Pilocarpine—glaucoma	0.000684	0.00284	CcSEcCtD
Spironolactone—Nausea—Carteolol—glaucoma	0.000683	0.00284	CcSEcCtD
Spironolactone—Headache—Levobunolol—glaucoma	0.00068	0.00283	CcSEcCtD
Spironolactone—Discomfort—Dorzolamide—glaucoma	0.00068	0.00283	CcSEcCtD
Spironolactone—Discomfort—Travoprost—glaucoma	0.000677	0.00282	CcSEcCtD
Spironolactone—Gastrointestinal disorder—Bimatoprost—glaucoma	0.000674	0.0028	CcSEcCtD
Spironolactone—Nausea—Diclofenamide—glaucoma	0.000671	0.00279	CcSEcCtD
Spironolactone—Discomfort—Brinzolamide—glaucoma	0.000669	0.00278	CcSEcCtD
Spironolactone—Dizziness—Latanoprost—glaucoma	0.000666	0.00277	CcSEcCtD
Spironolactone—Confusional state—Dorzolamide—glaucoma	0.000666	0.00277	CcSEcCtD
Spironolactone—Feeling abnormal—Apraclonidine—glaucoma	0.000664	0.00276	CcSEcCtD
Spironolactone—Vomiting—Methazolamide—glaucoma	0.000662	0.00275	CcSEcCtD
Spironolactone—Anaphylactic shock—Dorzolamide—glaucoma	0.00066	0.00274	CcSEcCtD
Spironolactone—Rash—Methazolamide—glaucoma	0.000656	0.00273	CcSEcCtD
Spironolactone—Dermatitis—Methazolamide—glaucoma	0.000655	0.00273	CcSEcCtD
Spironolactone—Nausea—Carbachol—glaucoma	0.000655	0.00272	CcSEcCtD
Spironolactone—Headache—Methazolamide—glaucoma	0.000652	0.00271	CcSEcCtD
Spironolactone—Nausea—Levobunolol—glaucoma	0.000645	0.00268	CcSEcCtD
Spironolactone—Discomfort—Pilocarpine—glaucoma	0.000643	0.00267	CcSEcCtD
Spironolactone—Somnolence—Acetazolamide—glaucoma	0.00064	0.00266	CcSEcCtD
Spironolactone—Rash—Latanoprost—glaucoma	0.000635	0.00264	CcSEcCtD
Spironolactone—Agranulocytosis—Betaxolol—glaucoma	0.000635	0.00264	CcSEcCtD
Spironolactone—Dermatitis—Latanoprost—glaucoma	0.000634	0.00264	CcSEcCtD
Spironolactone—Headache—Latanoprost—glaucoma	0.000631	0.00262	CcSEcCtD
Spironolactone—Confusional state—Pilocarpine—glaucoma	0.000629	0.00262	CcSEcCtD
Spironolactone—Gastrointestinal disorder—Acetazolamide—glaucoma	0.000622	0.00259	CcSEcCtD
Spironolactone—Alopecia—Clonidine—glaucoma	0.00062	0.00258	CcSEcCtD
Spironolactone—Nausea—Methazolamide—glaucoma	0.000618	0.00257	CcSEcCtD
Spironolactone—Somnolence—Brimonidine—glaucoma	0.000615	0.00256	CcSEcCtD
Spironolactone—Thrombocytopenia—Pilocarpine—glaucoma	0.000611	0.00254	CcSEcCtD
Spironolactone—Gastrointestinal disorder—Brimonidine—glaucoma	0.000597	0.00248	CcSEcCtD
Spironolactone—Feeling abnormal—Acetazolamide—glaucoma	0.000594	0.00247	CcSEcCtD
Spironolactone—Hypersensitivity—Apraclonidine—glaucoma	0.000593	0.00247	CcSEcCtD
Spironolactone—Somnolence—Dorzolamide—glaucoma	0.000587	0.00244	CcSEcCtD
Spironolactone—Muscle spasms—Clonidine—glaucoma	0.000587	0.00244	CcSEcCtD
Spironolactone—Fluoxymesterone—NR3C1—glaucoma	0.000581	0.0903	CrCbGaD
Spironolactone—Somnolence—Brinzolamide—glaucoma	0.000577	0.0024	CcSEcCtD
Spironolactone—Erectile dysfunction—Timolol—glaucoma	0.000574	0.00239	CcSEcCtD
Spironolactone—Urticaria—Acetazolamide—glaucoma	0.000572	0.00238	CcSEcCtD
Spironolactone—Pruritus—Apraclonidine—glaucoma	0.00057	0.00237	CcSEcCtD
Spironolactone—Body temperature increased—Acetazolamide—glaucoma	0.000569	0.00237	CcSEcCtD
Spironolactone—Gastrointestinal disorder—Travoprost—glaucoma	0.000567	0.00236	CcSEcCtD
Spironolactone—Ill-defined disorder—Clonidine—glaucoma	0.000566	0.00235	CcSEcCtD
Spironolactone—Gastrointestinal disorder—Brinzolamide—glaucoma	0.00056	0.00233	CcSEcCtD
Spironolactone—Somnolence—Pilocarpine—glaucoma	0.000555	0.00231	CcSEcCtD
Spironolactone—Pruritus—Bimatoprost—glaucoma	0.000552	0.0023	CcSEcCtD
Spironolactone—Diarrhoea—Apraclonidine—glaucoma	0.000551	0.00229	CcSEcCtD
Spironolactone—Malaise—Clonidine—glaucoma	0.00055	0.00229	CcSEcCtD
Spironolactone—Feeling abnormal—Dorzolamide—glaucoma	0.000544	0.00226	CcSEcCtD
Spironolactone—Feeling abnormal—Travoprost—glaucoma	0.000542	0.00225	CcSEcCtD
Spironolactone—Alopecia—Betaxolol—glaucoma	0.000539	0.00224	CcSEcCtD
Spironolactone—Gastrointestinal disorder—Pilocarpine—glaucoma	0.000539	0.00224	CcSEcCtD
Spironolactone—Feeling abnormal—Brinzolamide—glaucoma	0.000535	0.00222	CcSEcCtD
Spironolactone—Dizziness—Apraclonidine—glaucoma	0.000532	0.00221	CcSEcCtD
Spironolactone—Urticaria—Dorzolamide—glaucoma	0.000524	0.00218	CcSEcCtD
Spironolactone—Body temperature increased—Dorzolamide—glaucoma	0.000522	0.00217	CcSEcCtD
Spironolactone—Agranulocytosis—Timolol—glaucoma	0.000518	0.00216	CcSEcCtD
Spironolactone—Dizziness—Bimatoprost—glaucoma	0.000516	0.00215	CcSEcCtD
Spironolactone—Urticaria—Brinzolamide—glaucoma	0.000516	0.00214	CcSEcCtD
Spironolactone—Feeling abnormal—Pilocarpine—glaucoma	0.000514	0.00214	CcSEcCtD
Spironolactone—Discomfort—Clonidine—glaucoma	0.000513	0.00213	CcSEcCtD
Spironolactone—Vomiting—Apraclonidine—glaucoma	0.000512	0.00213	CcSEcCtD
Spironolactone—Muscle spasms—Betaxolol—glaucoma	0.000511	0.00212	CcSEcCtD
Spironolactone—Hypersensitivity—Brimonidine—glaucoma	0.000509	0.00212	CcSEcCtD
Spironolactone—Dermatitis—Apraclonidine—glaucoma	0.000507	0.00211	CcSEcCtD
Spironolactone—Headache—Apraclonidine—glaucoma	0.000504	0.0021	CcSEcCtD
Spironolactone—Confusional state—Clonidine—glaucoma	0.000502	0.00209	CcSEcCtD
Spironolactone—Medroxyprogesterone Acetate—NR3C1—glaucoma	0.000499	0.0775	CrCbGaD
Spironolactone—Body temperature increased—Pilocarpine—glaucoma	0.000493	0.00205	CcSEcCtD
Spironolactone—Ill-defined disorder—Betaxolol—glaucoma	0.000493	0.00205	CcSEcCtD
Spironolactone—Diarrhoea—Acetazolamide—glaucoma	0.000493	0.00205	CcSEcCtD
Spironolactone—Rash—Bimatoprost—glaucoma	0.000492	0.00205	CcSEcCtD
Spironolactone—Dermatitis—Bimatoprost—glaucoma	0.000492	0.00204	CcSEcCtD
Spironolactone—Pruritus—Brimonidine—glaucoma	0.000489	0.00203	CcSEcCtD
Spironolactone—Headache—Bimatoprost—glaucoma	0.000489	0.00203	CcSEcCtD
Spironolactone—Thrombocytopenia—Clonidine—glaucoma	0.000488	0.00203	CcSEcCtD
Spironolactone—Hypersensitivity—Dorzolamide—glaucoma	0.000486	0.00202	CcSEcCtD
Spironolactone—Hypersensitivity—Travoprost—glaucoma	0.000484	0.00201	CcSEcCtD
Spironolactone—Progesterone—CYP1B1—glaucoma	0.000484	0.0752	CrCbGaD
Spironolactone—Malaise—Betaxolol—glaucoma	0.000479	0.00199	CcSEcCtD
Spironolactone—Nausea—Apraclonidine—glaucoma	0.000478	0.00199	CcSEcCtD
Spironolactone—Hypersensitivity—Brinzolamide—glaucoma	0.000478	0.00199	CcSEcCtD
Spironolactone—Dizziness—Acetazolamide—glaucoma	0.000476	0.00198	CcSEcCtD
Spironolactone—Pruritus—Dorzolamide—glaucoma	0.000467	0.00194	CcSEcCtD
Spironolactone—Pruritus—Travoprost—glaucoma	0.000465	0.00193	CcSEcCtD
Spironolactone—Nausea—Bimatoprost—glaucoma	0.000464	0.00193	CcSEcCtD
Spironolactone—Hypersensitivity—Pilocarpine—glaucoma	0.00046	0.00191	CcSEcCtD
Spironolactone—Pruritus—Brinzolamide—glaucoma	0.000459	0.00191	CcSEcCtD
Spironolactone—Vomiting—Acetazolamide—glaucoma	0.000458	0.0019	CcSEcCtD
Spironolactone—Testosterone—CYP1B1—glaucoma	0.000458	0.0711	CrCbGaD
Spironolactone—Dizziness—Brimonidine—glaucoma	0.000457	0.0019	CcSEcCtD
Spironolactone—Diarrhoea—Dorzolamide—glaucoma	0.000452	0.00188	CcSEcCtD
Spironolactone—Headache—Acetazolamide—glaucoma	0.000451	0.00188	CcSEcCtD
Spironolactone—Diarrhoea—Travoprost—glaucoma	0.00045	0.00187	CcSEcCtD
Spironolactone—Discomfort—Betaxolol—glaucoma	0.000447	0.00186	CcSEcCtD
Spironolactone—Diarrhoea—Brinzolamide—glaucoma	0.000444	0.00185	CcSEcCtD
Spironolactone—Somnolence—Clonidine—glaucoma	0.000443	0.00184	CcSEcCtD
Spironolactone—Pruritus—Pilocarpine—glaucoma	0.000441	0.00184	CcSEcCtD
Spironolactone—Alopecia—Timolol—glaucoma	0.000441	0.00183	CcSEcCtD
Spironolactone—Confusional state—Betaxolol—glaucoma	0.000437	0.00182	CcSEcCtD
Spironolactone—Dizziness—Dorzolamide—glaucoma	0.000437	0.00182	CcSEcCtD
Spironolactone—Rash—Brimonidine—glaucoma	0.000436	0.00181	CcSEcCtD
Spironolactone—Dermatitis—Brimonidine—glaucoma	0.000435	0.00181	CcSEcCtD
Spironolactone—Dizziness—Travoprost—glaucoma	0.000435	0.00181	CcSEcCtD
Spironolactone—Headache—Brimonidine—glaucoma	0.000433	0.0018	CcSEcCtD
Spironolactone—Gastrointestinal disorder—Clonidine—glaucoma	0.00043	0.00179	CcSEcCtD
Spironolactone—Dizziness—Brinzolamide—glaucoma	0.000429	0.00178	CcSEcCtD
Spironolactone—Nausea—Acetazolamide—glaucoma	0.000428	0.00178	CcSEcCtD
Spironolactone—Diarrhoea—Pilocarpine—glaucoma	0.000427	0.00177	CcSEcCtD
Spironolactone—Thrombocytopenia—Betaxolol—glaucoma	0.000425	0.00177	CcSEcCtD
Spironolactone—Drospirenone—PTGS2—glaucoma	0.000424	0.0659	CrCbGaD
Spironolactone—Vomiting—Dorzolamide—glaucoma	0.00042	0.00175	CcSEcCtD
Spironolactone—Rash—Dorzolamide—glaucoma	0.000416	0.00173	CcSEcCtD
Spironolactone—Dermatitis—Dorzolamide—glaucoma	0.000416	0.00173	CcSEcCtD
Spironolactone—Rash—Travoprost—glaucoma	0.000414	0.00172	CcSEcCtD
Spironolactone—Dermatitis—Travoprost—glaucoma	0.000414	0.00172	CcSEcCtD
Spironolactone—Headache—Dorzolamide—glaucoma	0.000414	0.00172	CcSEcCtD
Spironolactone—Vomiting—Brinzolamide—glaucoma	0.000413	0.00172	CcSEcCtD
Spironolactone—Dizziness—Pilocarpine—glaucoma	0.000413	0.00172	CcSEcCtD
Spironolactone—Headache—Travoprost—glaucoma	0.000412	0.00171	CcSEcCtD
Spironolactone—Nausea—Brimonidine—glaucoma	0.000411	0.00171	CcSEcCtD
Spironolactone—Feeling abnormal—Clonidine—glaucoma	0.000411	0.00171	CcSEcCtD
Spironolactone—Rash—Brinzolamide—glaucoma	0.000409	0.0017	CcSEcCtD
Spironolactone—Dermatitis—Brinzolamide—glaucoma	0.000409	0.0017	CcSEcCtD
Spironolactone—Headache—Brinzolamide—glaucoma	0.000407	0.00169	CcSEcCtD
Spironolactone—AR—Regulation of Androgen receptor activity—NR3C1—glaucoma	0.000403	0.00435	CbGpPWpGaD
Spironolactone—Vomiting—Pilocarpine—glaucoma	0.000397	0.00165	CcSEcCtD
Spironolactone—Urticaria—Clonidine—glaucoma	0.000396	0.00165	CcSEcCtD
Spironolactone—Body temperature increased—Clonidine—glaucoma	0.000394	0.00164	CcSEcCtD
Spironolactone—Rash—Pilocarpine—glaucoma	0.000393	0.00164	CcSEcCtD
Spironolactone—Dermatitis—Pilocarpine—glaucoma	0.000393	0.00163	CcSEcCtD
Spironolactone—Nausea—Dorzolamide—glaucoma	0.000392	0.00163	CcSEcCtD
Spironolactone—Headache—Pilocarpine—glaucoma	0.000391	0.00162	CcSEcCtD
Spironolactone—Nausea—Travoprost—glaucoma	0.00039	0.00162	CcSEcCtD
Spironolactone—Nausea—Brinzolamide—glaucoma	0.000386	0.0016	CcSEcCtD
Spironolactone—Gastrointestinal disorder—Betaxolol—glaucoma	0.000374	0.00156	CcSEcCtD
Spironolactone—CYP11B2—Biological oxidations—CYP1B1—glaucoma	0.000374	0.00404	CbGpPWpGaD
Spironolactone—Nausea—Pilocarpine—glaucoma	0.000371	0.00154	CcSEcCtD
Spironolactone—CYP11B2—Metapathway biotransformation—CYP1B1—glaucoma	0.000369	0.00398	CbGpPWpGaD
Spironolactone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CCND2—glaucoma	0.000369	0.00397	CbGpPWpGaD
Spironolactone—Hypersensitivity—Clonidine—glaucoma	0.000367	0.00153	CcSEcCtD
Spironolactone—Discomfort—Timolol—glaucoma	0.000365	0.00152	CcSEcCtD
Spironolactone—AR—SIDS Susceptibility Pathways—HDAC9—glaucoma	0.00036	0.00388	CbGpPWpGaD
Spironolactone—Feeling abnormal—Betaxolol—glaucoma	0.000357	0.00149	CcSEcCtD
Spironolactone—Confusional state—Timolol—glaucoma	0.000357	0.00149	CcSEcCtD
Spironolactone—Anaphylactic shock—Timolol—glaucoma	0.000354	0.00147	CcSEcCtD
Spironolactone—Hydrocortisone—NR3C1—glaucoma	0.000353	0.0549	CrCbGaD
Spironolactone—Pruritus—Clonidine—glaucoma	0.000352	0.00147	CcSEcCtD
Spironolactone—CYP11B2—Metabolism of lipids and lipoproteins—CTSA—glaucoma	0.00035	0.00377	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—PITX2—glaucoma	0.000348	0.00376	CbGpPWpGaD
Spironolactone—Urticaria—Betaxolol—glaucoma	0.000345	0.00143	CcSEcCtD
Spironolactone—Body temperature increased—Betaxolol—glaucoma	0.000343	0.00143	CcSEcCtD
Spironolactone—Diarrhoea—Clonidine—glaucoma	0.000341	0.00142	CcSEcCtD
Spironolactone—ABCC2—NRF2 pathway—TXN—glaucoma	0.00034	0.00367	CbGpPWpGaD
Spironolactone—Dizziness—Clonidine—glaucoma	0.000329	0.00137	CcSEcCtD
Spironolactone—CYP11B2—Metabolism—NARFL—glaucoma	0.000329	0.00355	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—CA5A—glaucoma	0.000329	0.00355	CbGpPWpGaD
Spironolactone—AR—Regulation of nuclear SMAD2/3 signaling—CDKN2B—glaucoma	0.000327	0.00353	CbGpPWpGaD
Spironolactone—SLCO1A2—Transmembrane transport of small molecules—PEX19—glaucoma	0.000323	0.00348	CbGpPWpGaD
Spironolactone—CYP11B1—Biological oxidations—CYP1B1—glaucoma	0.000323	0.00348	CbGpPWpGaD
Spironolactone—Hypersensitivity—Betaxolol—glaucoma	0.00032	0.00133	CcSEcCtD
Spironolactone—CYP11B1—Metapathway biotransformation—CYP1B1—glaucoma	0.000318	0.00343	CbGpPWpGaD
Spironolactone—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—glaucoma	0.000317	0.00342	CbGpPWpGaD
Spironolactone—Vomiting—Clonidine—glaucoma	0.000317	0.00132	CcSEcCtD
Spironolactone—Somnolence—Timolol—glaucoma	0.000315	0.00131	CcSEcCtD
Spironolactone—Rash—Clonidine—glaucoma	0.000314	0.00131	CcSEcCtD
Spironolactone—Dermatitis—Clonidine—glaucoma	0.000314	0.0013	CcSEcCtD
Spironolactone—Headache—Clonidine—glaucoma	0.000312	0.0013	CcSEcCtD
Spironolactone—Pruritus—Betaxolol—glaucoma	0.000307	0.00128	CcSEcCtD
Spironolactone—Gastrointestinal disorder—Timolol—glaucoma	0.000306	0.00127	CcSEcCtD
Spironolactone—ABCC2—NRF2 pathway—SLC6A1—glaucoma	0.000303	0.00327	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism of lipids and lipoproteins—CTSA—glaucoma	0.000301	0.00325	CbGpPWpGaD
Spironolactone—CYP11B2—Biological oxidations—GSTM1—glaucoma	0.000299	0.00323	CbGpPWpGaD
Spironolactone—Diarrhoea—Betaxolol—glaucoma	0.000297	0.00123	CcSEcCtD
Spironolactone—Nausea—Clonidine—glaucoma	0.000296	0.00123	CcSEcCtD
Spironolactone—CYP11B2—Metapathway biotransformation—GSTM1—glaucoma	0.000295	0.00318	CbGpPWpGaD
Spironolactone—ABCC2—Transmembrane transport of small molecules—PEX19—glaucoma	0.000294	0.00317	CbGpPWpGaD
Spironolactone—Feeling abnormal—Timolol—glaucoma	0.000292	0.00121	CcSEcCtD
Spironolactone—Progesterone—NR3C1—glaucoma	0.000288	0.0447	CrCbGaD
Spironolactone—AR—Regulation of nuclear SMAD2/3 signaling—NR3C1—glaucoma	0.000287	0.0031	CbGpPWpGaD
Spironolactone—Dizziness—Betaxolol—glaucoma	0.000287	0.00119	CcSEcCtD
Spironolactone—SLCO1A2—SLC-mediated transmembrane transport—SLC6A13—glaucoma	0.000287	0.00309	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—CA5A—glaucoma	0.000284	0.00306	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—NARFL—glaucoma	0.000284	0.00306	CbGpPWpGaD
Spironolactone—Urticaria—Timolol—glaucoma	0.000281	0.00117	CcSEcCtD
Spironolactone—Body temperature increased—Timolol—glaucoma	0.00028	0.00116	CcSEcCtD
Spironolactone—Vomiting—Betaxolol—glaucoma	0.000276	0.00115	CcSEcCtD
Spironolactone—Rash—Betaxolol—glaucoma	0.000273	0.00114	CcSEcCtD
Spironolactone—NR3C1—SIDS Susceptibility Pathways—HDAC9—glaucoma	0.000273	0.00295	CbGpPWpGaD
Spironolactone—Dermatitis—Betaxolol—glaucoma	0.000273	0.00114	CcSEcCtD
Spironolactone—Headache—Betaxolol—glaucoma	0.000272	0.00113	CcSEcCtD
Spironolactone—AR—FOXA1 transcription factor network—CDKN1B—glaucoma	0.00027	0.00291	CbGpPWpGaD
Spironolactone—NR3C1—AP-1 transcription factor network—EDN1—glaucoma	0.000268	0.00289	CbGpPWpGaD
Spironolactone—CYP2C8—Arachidonic acid metabolism—CYP1B1—glaucoma	0.000267	0.00288	CbGpPWpGaD
Spironolactone—CYP11B1—Corticotropin-releasing hormone—NOS3—glaucoma	0.000262	0.00283	CbGpPWpGaD
Spironolactone—Hypersensitivity—Timolol—glaucoma	0.000261	0.00109	CcSEcCtD
Spironolactone—CYP11B1—Biological oxidations—GSTM1—glaucoma	0.000258	0.00278	CbGpPWpGaD
Spironolactone—AR—SIDS Susceptibility Pathways—NTRK2—glaucoma	0.000258	0.00278	CbGpPWpGaD
Spironolactone—Nausea—Betaxolol—glaucoma	0.000258	0.00107	CcSEcCtD
Spironolactone—AR—Notch-mediated HES/HEY network—CDKN1B—glaucoma	0.000256	0.00276	CbGpPWpGaD
Spironolactone—CYP11B1—Metapathway biotransformation—GSTM1—glaucoma	0.000254	0.00274	CbGpPWpGaD
Spironolactone—NR3C1—Transcription factor regulation in adipogenesis—TNF—glaucoma	0.000254	0.00274	CbGpPWpGaD
Spironolactone—Pruritus—Timolol—glaucoma	0.000251	0.00104	CcSEcCtD
Spironolactone—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDKN2B—glaucoma	0.000248	0.00268	CbGpPWpGaD
Spironolactone—ABCC2—NRF2 pathway—TGFB2—glaucoma	0.000247	0.00266	CbGpPWpGaD
Spironolactone—Diarrhoea—Timolol—glaucoma	0.000242	0.00101	CcSEcCtD
Spironolactone—AR—Integrated Pancreatic Cancer Pathway—SMO—glaucoma	0.00024	0.00258	CbGpPWpGaD
Spironolactone—AR—Coregulation of Androgen receptor activity—CDKN2A—glaucoma	0.000235	0.00253	CbGpPWpGaD
Spironolactone—AR—Androgen receptor signaling pathway—CAV1—glaucoma	0.000235	0.00253	CbGpPWpGaD
Spironolactone—Dizziness—Timolol—glaucoma	0.000234	0.000974	CcSEcCtD
Spironolactone—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	0.000231	0.00249	CbGpPWpGaD
Spironolactone—CYP2C8—Oxidation by Cytochrome P450—CYP1B1—glaucoma	0.000228	0.00246	CbGpPWpGaD
Spironolactone—Vomiting—Timolol—glaucoma	0.000225	0.000937	CcSEcCtD
Spironolactone—NR3C1—AP-1 transcription factor network—MMP1—glaucoma	0.000225	0.00243	CbGpPWpGaD
Spironolactone—Rash—Timolol—glaucoma	0.000223	0.000929	CcSEcCtD
Spironolactone—Dermatitis—Timolol—glaucoma	0.000223	0.000928	CcSEcCtD
Spironolactone—Headache—Timolol—glaucoma	0.000222	0.000923	CcSEcCtD
Spironolactone—SLCO1A2—Transmembrane transport of small molecules—SLC4A4—glaucoma	0.000218	0.00235	CbGpPWpGaD
Spironolactone—Nausea—Timolol—glaucoma	0.00021	0.000875	CcSEcCtD
Spironolactone—SLCO1A2—SLC-mediated transmembrane transport—SLC6A1—glaucoma	0.00021	0.00226	CbGpPWpGaD
Spironolactone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MMP2—glaucoma	0.000206	0.00222	CbGpPWpGaD
Spironolactone—ABCC2—Transmembrane transport of small molecules—SLC4A4—glaucoma	0.000199	0.00214	CbGpPWpGaD
Spironolactone—NR3C1—Glucocorticoid receptor regulatory network—MMP1—glaucoma	0.000198	0.00214	CbGpPWpGaD
Spironolactone—NR3C1—SIDS Susceptibility Pathways—NTRK2—glaucoma	0.000196	0.00211	CbGpPWpGaD
Spironolactone—AR—SIDS Susceptibility Pathways—BDNF—glaucoma	0.000192	0.00207	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism of lipids and lipoproteins—CTSA—glaucoma	0.000189	0.00204	CbGpPWpGaD
Spironolactone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CDKN2A—glaucoma	0.000189	0.00204	CbGpPWpGaD
Spironolactone—PGR—Signaling by ERBB4—BAD—glaucoma	0.000189	0.00203	CbGpPWpGaD
Spironolactone—CYP2C8—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	0.000187	0.00202	CbGpPWpGaD
Spironolactone—AR—SIDS Susceptibility Pathways—IL1A—glaucoma	0.000185	0.00199	CbGpPWpGaD
Spironolactone—AR—Integrated Pancreatic Cancer Pathway—NTRK1—glaucoma	0.000179	0.00193	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—CA5A—glaucoma	0.000178	0.00192	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—NARFL—glaucoma	0.000178	0.00192	CbGpPWpGaD
Spironolactone—NR3C2—Generic Transcription Pathway—CDKN2B—glaucoma	0.000176	0.0019	CbGpPWpGaD
Spironolactone—AR—SIDS Susceptibility Pathways—NGF—glaucoma	0.000171	0.00184	CbGpPWpGaD
Spironolactone—AR—SIDS Susceptibility Pathways—NR3C1—glaucoma	0.00017	0.00183	CbGpPWpGaD
Spironolactone—ABCC2—NRF2 pathway—GSTM1—glaucoma	0.000168	0.00181	CbGpPWpGaD
Spironolactone—AR—Integrated Pancreatic Cancer Pathway—CDKN2B—glaucoma	0.000165	0.00178	CbGpPWpGaD
Spironolactone—AR—Integrated Pancreatic Cancer Pathway—BDNF—glaucoma	0.000164	0.00176	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—CA1—glaucoma	0.000161	0.00173	CbGpPWpGaD
Spironolactone—AR—Integrated Breast Cancer Pathway—MMP1—glaucoma	0.00016	0.00173	CbGpPWpGaD
Spironolactone—NR3C1—AP-1 transcription factor network—CDKN2A—glaucoma	0.00016	0.00172	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—CTSA—glaucoma	0.000156	0.00168	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—LRP12—glaucoma	0.000155	0.00168	CbGpPWpGaD
Spironolactone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MMP9—glaucoma	0.000155	0.00167	CbGpPWpGaD
Spironolactone—NR3C2—Generic Transcription Pathway—NR3C1—glaucoma	0.000155	0.00167	CbGpPWpGaD
Spironolactone—ABCB1—HIF-1-alpha transcription factor network—EDN1—glaucoma	0.000151	0.00163	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—CA2—glaucoma	0.000147	0.00159	CbGpPWpGaD
Spironolactone—NR3C1—SIDS Susceptibility Pathways—BDNF—glaucoma	0.000146	0.00157	CbGpPWpGaD
Spironolactone—SLCO1A2—Transmembrane transport of small molecules—SLC6A13—glaucoma	0.000146	0.00157	CbGpPWpGaD
Spironolactone—AR—Integrated Breast Cancer Pathway—BAD—glaucoma	0.000145	0.00156	CbGpPWpGaD
Spironolactone—NR3C1—Adipogenesis—FAS—glaucoma	0.000145	0.00156	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	0.000144	0.00155	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	0.000144	0.00155	CbGpPWpGaD
Spironolactone—NR3C1—AP-1 transcription factor network—CDKN1B—glaucoma	0.000141	0.00152	CbGpPWpGaD
Spironolactone—NR3C1—SIDS Susceptibility Pathways—IL1A—glaucoma	0.00014	0.00151	CbGpPWpGaD
Spironolactone—AR—Integrated Pancreatic Cancer Pathway—FAS—glaucoma	0.00014	0.00151	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—CA1—glaucoma	0.000139	0.00149	CbGpPWpGaD
Spironolactone—ABCB1—Transmembrane transport of small molecules—PEX19—glaucoma	0.000138	0.00149	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—CTSA—glaucoma	0.000134	0.00145	CbGpPWpGaD
Spironolactone—ABCC2—Transmembrane transport of small molecules—SLC6A13—glaucoma	0.000133	0.00143	CbGpPWpGaD
Spironolactone—PGR—Signaling by ERBB4—CDKN1B—glaucoma	0.000131	0.00142	CbGpPWpGaD
Spironolactone—NR3C1—AP-1 transcription factor network—MMP9—glaucoma	0.000131	0.00141	CbGpPWpGaD
Spironolactone—ABCB1—Allograft Rejection—IL1A—glaucoma	0.00013	0.0014	CbGpPWpGaD
Spironolactone—NR3C1—SIDS Susceptibility Pathways—NGF—glaucoma	0.00013	0.0014	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—CA2—glaucoma	0.000127	0.00137	CbGpPWpGaD
Spironolactone—CYP2C8—Biological oxidations—GSTT1—glaucoma	0.000125	0.00135	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	0.000124	0.00134	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	0.000124	0.00134	CbGpPWpGaD
Spironolactone—CYP2C8—Arachidonic acid metabolism—PTGS2—glaucoma	0.00012	0.0013	CbGpPWpGaD
Spironolactone—AR—Integrated Pancreatic Cancer Pathway—BAD—glaucoma	0.00012	0.00129	CbGpPWpGaD
Spironolactone—ABCB1—Allograft Rejection—FAS—glaucoma	0.000116	0.00125	CbGpPWpGaD
Spironolactone—ABCB1—Allograft Rejection—C3—glaucoma	0.000114	0.00123	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—OPN4—glaucoma	0.000108	0.00116	CbGpPWpGaD
Spironolactone—PGR—Generic Transcription Pathway—CDKN2B—glaucoma	0.000107	0.00116	CbGpPWpGaD
Spironolactone—SLCO1A2—Transmembrane transport of small molecules—SLC6A1—glaucoma	0.000107	0.00115	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—TXN—glaucoma	0.000104	0.00112	CbGpPWpGaD
Spironolactone—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—glaucoma	0.000101	0.00109	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—HEYL—glaucoma	0.0001	0.00108	CbGpPWpGaD
Spironolactone—CYP2C8—Biological oxidations—CYP1B1—glaucoma	9.94e-05	0.00107	CbGpPWpGaD
Spironolactone—CYP2C8—Metapathway biotransformation—CYP1B1—glaucoma	9.8e-05	0.00106	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—SMO—glaucoma	9.77e-05	0.00105	CbGpPWpGaD
Spironolactone—ABCC2—Transmembrane transport of small molecules—SLC6A1—glaucoma	9.7e-05	0.00105	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—PTGFR—glaucoma	9.7e-05	0.00105	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism of lipids and lipoproteins—APOE—glaucoma	9.46e-05	0.00102	CbGpPWpGaD
Spironolactone—PGR—Generic Transcription Pathway—NR3C1—glaucoma	9.42e-05	0.00102	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism of lipids and lipoproteins—CAV1—glaucoma	9.37e-05	0.00101	CbGpPWpGaD
Spironolactone—ABCB1—Transmembrane transport of small molecules—SLC4A4—glaucoma	9.34e-05	0.00101	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—CTSA—glaucoma	9.29e-05	0.001	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—TXN—glaucoma	8.93e-05	0.000963	CbGpPWpGaD
Spironolactone—NR3C1—AP-1 transcription factor network—TP53—glaucoma	8.88e-05	0.000957	CbGpPWpGaD
Spironolactone—AR—Integrated Pancreatic Cancer Pathway—PTGS2—glaucoma	8.81e-05	0.00095	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—NARFL—glaucoma	8.74e-05	0.000943	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—CA5A—glaucoma	8.74e-05	0.000943	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—CA1—glaucoma	8.69e-05	0.000937	CbGpPWpGaD
Spironolactone—NR3C2—Gene Expression—CDKN2B—glaucoma	8.49e-05	0.000915	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—CTSA—glaucoma	8.42e-05	0.000908	CbGpPWpGaD
Spironolactone—AR—Integrated Breast Cancer Pathway—VEGFA—glaucoma	8.37e-05	0.000903	CbGpPWpGaD
Spironolactone—AR—Integrated Pancreatic Cancer Pathway—CDKN1B—glaucoma	8.34e-05	0.000899	CbGpPWpGaD
Spironolactone—AR—Generic Transcription Pathway—CDKN2B—glaucoma	8.18e-05	0.000882	CbGpPWpGaD
Spironolactone—AR—SIDS Susceptibility Pathways—VEGFA—glaucoma	8.16e-05	0.00088	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism of lipids and lipoproteins—APOE—glaucoma	8.15e-05	0.000879	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism of lipids and lipoproteins—CAV1—glaucoma	8.07e-05	0.000871	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—GSTT1—glaucoma	8.04e-05	0.000867	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—CA2—glaucoma	7.95e-05	0.000857	CbGpPWpGaD
Spironolactone—CYP2C8—Biological oxidations—GSTM1—glaucoma	7.95e-05	0.000857	CbGpPWpGaD
Spironolactone—CYP2C8—Metapathway biotransformation—GSTM1—glaucoma	7.84e-05	0.000845	CbGpPWpGaD
Spironolactone—NR3C1—Glucocorticoid receptor regulatory network—TP53—glaucoma	7.82e-05	0.000843	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	7.77e-05	0.000838	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	7.77e-05	0.000838	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—NARFL—glaucoma	7.62e-05	0.000821	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—CA5A—glaucoma	7.62e-05	0.000821	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—RPTOR—glaucoma	7.59e-05	0.000819	CbGpPWpGaD
Spironolactone—NR3C2—Gene Expression—NR3C1—glaucoma	7.45e-05	0.000803	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—NCK2—glaucoma	7.35e-05	0.000793	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—NTRK1—glaucoma	7.28e-05	0.000785	CbGpPWpGaD
Spironolactone—AR—Generic Transcription Pathway—NR3C1—glaucoma	7.18e-05	0.000774	CbGpPWpGaD
Spironolactone—AR—SIDS Susceptibility Pathways—TNF—glaucoma	6.99e-05	0.000754	CbGpPWpGaD
Spironolactone—AR—Integrated Pancreatic Cancer Pathway—VEGFA—glaucoma	6.94e-05	0.000748	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—GSTT1—glaucoma	6.93e-05	0.000747	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN2B—glaucoma	6.71e-05	0.000724	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—glaucoma	6.67e-05	0.000719	CbGpPWpGaD
Spironolactone—ABCB1—HIF-1-alpha transcription factor network—VEGFA—glaucoma	6.62e-05	0.000713	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	6.48e-05	0.000699	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—ABCA1—glaucoma	6.4e-05	0.00069	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—CYP1B1—glaucoma	6.4e-05	0.00069	CbGpPWpGaD
Spironolactone—AR—Integrated Breast Cancer Pathway—TP53—glaucoma	6.33e-05	0.000682	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—HDAC9—glaucoma	6.25e-05	0.000674	CbGpPWpGaD
Spironolactone—ABCB1—Transmembrane transport of small molecules—SLC6A13—glaucoma	6.23e-05	0.000672	CbGpPWpGaD
Spironolactone—NR3C1—Generic Transcription Pathway—CDKN2B—glaucoma	6.21e-05	0.000669	CbGpPWpGaD
Spironolactone—NR3C1—SIDS Susceptibility Pathways—VEGFA—glaucoma	6.19e-05	0.000667	CbGpPWpGaD
Spironolactone—NR3C1—Adipogenesis—TNF—glaucoma	6.14e-05	0.000662	CbGpPWpGaD
Spironolactone—AR—Integrated Pancreatic Cancer Pathway—TNF—glaucoma	5.95e-05	0.000641	CbGpPWpGaD
Spironolactone—ABCB1—Allograft Rejection—VEGFA—glaucoma	5.73e-05	0.000618	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—glaucoma	5.71e-05	0.000615	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—TXN—glaucoma	5.6e-05	0.000604	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	5.58e-05	0.000602	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—CYP1B1—glaucoma	5.52e-05	0.000595	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—ABCA1—glaucoma	5.52e-05	0.000595	CbGpPWpGaD
Spironolactone—NR3C1—SIDS Susceptibility Pathways—TNF—glaucoma	5.3e-05	0.000572	CbGpPWpGaD
Spironolactone—AR—Integrated Pancreatic Cancer Pathway—TP53—glaucoma	5.24e-05	0.000565	CbGpPWpGaD
Spironolactone—PGR—Gene Expression—CDKN2B—glaucoma	5.17e-05	0.000557	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—GSTM1—glaucoma	5.12e-05	0.000552	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism of lipids and lipoproteins—APOE—glaucoma	5.11e-05	0.000551	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism of lipids and lipoproteins—CAV1—glaucoma	5.06e-05	0.000546	CbGpPWpGaD
Spironolactone—ABCB1—Allograft Rejection—TNF—glaucoma	4.91e-05	0.000529	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—SMO—glaucoma	4.89e-05	0.000528	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—BAD—glaucoma	4.88e-05	0.000526	CbGpPWpGaD
Spironolactone—ABCB1—Transmembrane transport of small molecules—SLC6A1—glaucoma	4.56e-05	0.000492	CbGpPWpGaD
Spironolactone—PGR—Gene Expression—NR3C1—glaucoma	4.54e-05	0.000489	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—MTHFR—glaucoma	4.52e-05	0.000488	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—NTRK2—glaucoma	4.47e-05	0.000482	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—GSTM1—glaucoma	4.41e-05	0.000476	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—GSTT1—glaucoma	4.34e-05	0.000468	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—CA1—glaucoma	4.27e-05	0.00046	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—APOE—glaucoma	4.21e-05	0.000454	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—CAV1—glaucoma	4.17e-05	0.00045	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—CTSA—glaucoma	4.14e-05	0.000446	CbGpPWpGaD
Spironolactone—AR—Gene Expression—CDKN2B—glaucoma	3.94e-05	0.000425	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—CA2—glaucoma	3.91e-05	0.000421	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—MTHFR—glaucoma	3.9e-05	0.00042	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—NGFR—glaucoma	3.84e-05	0.000414	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	3.82e-05	0.000412	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	3.82e-05	0.000412	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—CA1—glaucoma	3.72e-05	0.000401	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—NTRK1—glaucoma	3.65e-05	0.000393	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—APOE—glaucoma	3.63e-05	0.000391	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—CTSA—glaucoma	3.6e-05	0.000389	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—CAV1—glaucoma	3.6e-05	0.000388	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—glaucoma	3.59e-05	0.000387	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	3.5e-05	0.000378	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—ABCA1—glaucoma	3.46e-05	0.000373	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—CYP1B1—glaucoma	3.46e-05	0.000373	CbGpPWpGaD
Spironolactone—AR—Gene Expression—NR3C1—glaucoma	3.46e-05	0.000373	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—CA2—glaucoma	3.4e-05	0.000367	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—glaucoma	3.4e-05	0.000367	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—CDKN2B—glaucoma	3.36e-05	0.000362	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—EDN1—glaucoma	3.23e-05	0.000348	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—NOS3—glaucoma	3.16e-05	0.00034	CbGpPWpGaD
Spironolactone—NR3C1—Gene Expression—CDKN2B—glaucoma	2.99e-05	0.000322	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—NGF—glaucoma	2.96e-05	0.00032	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—PTGS2—glaucoma	2.89e-05	0.000311	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—glaucoma	2.83e-05	0.000305	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—C3—glaucoma	2.82e-05	0.000304	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—GSTM1—glaucoma	2.77e-05	0.000298	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—TXN—glaucoma	2.75e-05	0.000297	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—NOS3—glaucoma	2.72e-05	0.000293	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—APOE—glaucoma	2.62e-05	0.000283	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—CAV1—glaucoma	2.6e-05	0.00028	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—APOE—glaucoma	2.51e-05	0.000271	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—CAV1—glaucoma	2.49e-05	0.000268	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—PTGS2—glaucoma	2.49e-05	0.000268	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—FN1—glaucoma	2.47e-05	0.000267	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—BAD—glaucoma	2.44e-05	0.000264	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—MTHFR—glaucoma	2.44e-05	0.000264	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—glaucoma	2.42e-05	0.000261	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—TXN—glaucoma	2.4e-05	0.000259	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—APOE—glaucoma	2.28e-05	0.000245	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—CAV1—glaucoma	2.25e-05	0.000243	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—glaucoma	2.14e-05	0.00023	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—GSTT1—glaucoma	2.13e-05	0.00023	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—NOS3—glaucoma	1.97e-05	0.000212	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—GSTT1—glaucoma	1.86e-05	0.0002	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	1.72e-05	0.000186	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—NOS3—glaucoma	1.7e-05	0.000184	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—CDKN1B—glaucoma	1.7e-05	0.000184	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—ABCA1—glaucoma	1.7e-05	0.000183	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—CYP1B1—glaucoma	1.7e-05	0.000183	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—MMP9—glaucoma	1.58e-05	0.00017	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—PTGS2—glaucoma	1.56e-05	0.000168	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—ABCA1—glaucoma	1.48e-05	0.00016	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—CYP1B1—glaucoma	1.48e-05	0.00016	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—VEGFA—glaucoma	1.42e-05	0.000153	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—GSTM1—glaucoma	1.36e-05	0.000147	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—MTHFR—glaucoma	1.2e-05	0.00013	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—GSTM1—glaucoma	1.18e-05	0.000128	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—APOE—glaucoma	1.12e-05	0.000121	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—CAV1—glaucoma	1.11e-05	0.000119	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—TP53—glaucoma	1.07e-05	0.000115	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—MTHFR—glaucoma	1.05e-05	0.000113	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—APOE—glaucoma	9.74e-06	0.000105	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—CAV1—glaucoma	9.65e-06	0.000104	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—NOS3—glaucoma	8.38e-06	9.03e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—PTGS2—glaucoma	7.66e-06	8.26e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—NOS3—glaucoma	7.3e-06	7.87e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—PTGS2—glaucoma	6.68e-06	7.2e-05	CbGpPWpGaD
